Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. is a medical device company specializing in regenerative solutions and biologics for use in spine, trauma, and infection management. The company focuses on developing and commercializing products derived from human tissues and other biomaterials to support tissue repair and regeneration in various surgical procedures.
Company News
BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of two amniotic membrane allografts, SimpliGraft™ and SimpliMax™.
Upgrades Piper Sandler upgraded the previous rating for BankUnited Inc (NYSE:BKU) from Underweight to Neutral. For the first quarter, BankUnited had an EPS of $0.70, compared to year-ago quarter EPS of $0.79. At the moment, the stock has a 52-week-high of $42.19 and a 52-week-low of $19.04. BankUnited closed at $20.86 at the end of the last tradi...